Functional single nucleotide polymorphism-based association studies

Human Genomics

Volumn 2, Issue 6, 2006, Pages 391-402

  Carlton, Victoria E H ^a   Ireland, James S ^a   Useche, Francisco ^a   Faham, Malek ^a  

^a Thermo Fisher Scientific   (United States)

Author keywords

Association studies; Functional SNPs; Human disease

Indexed keywords

APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR 5; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CHECKPOINT KINASE 2; CHEMOKINE RECEPTOR CCR5; COMPLEMENT FACTOR H; PROTHROMBIN;

ALLELE; ALZHEIMER DISEASE; ANALYTICAL ERROR; AUTOIMMUNE DISEASE; BREAST CANCER; CROHN DISEASE; DEEP VEIN THROMBOSIS; FUNCTIONAL GENOMICS; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC DISORDER; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN GENOME; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION GENETICS; PREDICTION; PROMOTER REGION; RETINA MACULA DEGENERATION; REVIEW; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION PROCESS;

EID: 33746375383     PISSN: 14797364     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/1479-7364-2-6-391     Document Type: Review

References (170)

1. Risch, N. and Merikangas, K. (1996), 'The future of genetic studies of complex human diseases', Science Vol. 273, pp. 1516-1517.
2. Lohmueller, K.E., Pearce, C.L., Pike, M. et al. (2003), 'Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease', Nat. Genet. Vol. 33, pp. 177-182.
3. Begovich, A.B., Carlton, V.E.H., Honigberg, L.A. et al. (2004), 'A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis', Am. J. Hum. Genet. Vol. 75, pp. 330-337.
4. van Oene, M., Wintle, R.F., Liu, X. et al. (2005), 'Association of the lymphoid. tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations', Arthritis Rheum. Vol. 52, pp. 1993-1998.
5. Simkins, H.M., Merriman, M.E., Highton, J. et al. (2005), 'Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort', Arthritis Rheum. Vol. 52, pp. 2222-2225.
6. Hinks, A., Barton, A., John, S. et al. (2005), 'Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: Further support that PTPN22 is an autoimmunity gene', Arthritis Rheum. Vol. 52, pp. 1694-1699.
7. Zhernakova, A., Eerligh, R, Wijmenga, C. et al. (2005), 'Differential association of the PTPN22 coding variant with autoimmune diseases in a Dutch population', Genes Immun. Vol. 6, pp. 459-461.
8. Viken, M.K., Amundsen, S.S., Kvien, T.K. et al. (2005), 'Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases', Genes Immun. Vol. 6, pp. 271-273.
9. Criswell, L.A., Pfeiffer, K.A., Lum, R.F., et al. (2005), 'Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: The PTPN22 620W allele associates with multiple autoimmune phenotypes', Am. J. Hum. Genet. Vol. 76, pp. 561-571.
10. Lee, A.T., Li, W, Liew, A. et al. (2005), 'The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status', Genes Immun. Vol. 6, pp. 129-133.
11. Orozco, G., Sanchez, E., Gonzalez-Gay, M.A. et al. (2005), 'Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus', Arthritis Rheum. Vol. 52, pp. 219-224.
12. Steer, S., Lad, B., Grumley, J.A. et al. (2005), 'Association of R602W in a protein tyrosine phosphatase gene with a high risk of rheumatoid arthritis in a British population: Evidence for an early onset/disease severity effect', Arthritis Rheum. Vol. 52, pp. 358-360.
13. Seldin, M.F., Shigeta, R., Laiho, K. et al. (2005), 'Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis', Genes Immun. Vol. 6, pp. 720-722.
14. Mori, M., Yamada, R., Kobayashi, K. et al. (2005), 'Ethnic differences in allele frequency of autoimmune-disease-associated SNPs', J. Hum. Genet. Vol. 50, pp. 264-266.
15. Qu, H., Tessier, M.C., Hudson, T.J. and Polychronakos, C. (2005), 'Confirmation of the association of the R620W polymorphism in the protein tyrosine phosphatase PTPN22 with type 1 diabetes in a family based study', J. Med. Genet. Vol. 42, pp. 266-270.
16. Zheng, W. and She, J.X. (2005), 'Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes', Diabetes Vol. 54, pp. 906-908.
17. Ladner, M.B., Bottini, N., Valdes, A.M. and Noble, J.A. (2005), 'Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes', Hum. Immunol. Vol. 66, pp. 60-64.
18. Onengut-Gumuscu, S., Ewens, K.G., Spielman, R.S. and Concannon, P. (2004), 'A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type I diabetes in multiplex families', Genes Immun. Vol. 5, pp. 678-680.
19. Smyth, D., Cooper, J.D., Collins, J.E. et al. (2004), 'Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/ PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus', Diabetes Vol. 53, pp. 3020-3023.
20. Bottini, N., Musumeci, L., Alonso, A. et al. (2004), 'A functional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes', Nat. Genet. Vol. 36, pp. 337-338.
21. Klein, R.J., Zeiss, C., Chew, E.Y. et al. (2005), 'Complement factor H polymorphism in age-related macular degeneration', Science Vol. 308, pp. 385-389.
22. Edwards, A.O., Ritter III, R., Abel, K.J. et al. (2005), 'Complement factor H polymorphism and age-related macular degeneration', Science Vol. 308, pp. 421-424.
23. Conley; Y.P., Thalamuthu, A., Jakobsdottir, J. et al. (2005), 'Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy', Hum. Mol. Genet. Vol. 14, pp. 1991-2002.
24. Hageman, G.S., Anderson, D.H., Johnson, L.V. et al. (2005), 'A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration', Proc. Natl. Acad. Sci. USA Vol. 102, pp. 7227-7232.
25. Haines, J.L., Hauser, M.A., Schmidt, S. et al. (2005), 'Complement factor H variant increases the risk of age-related macular degeneration', Science Vol. 308, pp. 419-421.
26. Zareparsi, S., Branham, K.E.H., Li, M. et al. (2005), 'Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration', Am. J. Hum. Genet. Vol. 77, pp. 149-153.
27. Bertina, R.M., Koeleman, B.P.C., Koster, T. et al. (1994), 'Mutation in blood coagulation factor V associated with resistance to activated protein C', Nature Vol. 369, pp. 64-67.
28. Ridker, P.M., Hennekens, C.H., Lindpaintner, K. et al. (1995), 'Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men', N Engl. J. Med. Vol. 332, pp. 912-917.
29. Zoller, B. and Dahlback, B. (1994), 'Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis', Lancet Vol. 343, pp, 1536-1538.
30. Zoller, B., Svensson, P.J., He, X. and Dahlback, B. (1994), 'Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C', J. Clin. Invest. Vol. 94, pp. 2521-2524.
31. Ma, D.D., Aboud, M.R., Williams, B.G. and Isbister, J.P. (1995), 'Activated protein c resistance (APC) and inherited factor V (FV) mis-sense mutation in patients with venous and arterial thrombosis in a haematology clinic', Aust. N. Z. J. Med. Vol. 25, pp. 151-154.
32. Ridker, P.M., Miletich, J.P., Stampfer, M.J. et al. (1995), 'Factor V Leiden and risks of recurrent idiopathic venous thromboembolism', Circulation Vol. 92, pp. 2800-2802.
33. Arruda, V.R., Annichino-Bizzacchi, J.M., Costa, F.F. and Reitsma, P.H. (1995), 'Factor V Leiden (FVQ 506) is common in a Brazilian population', Am. J. Hematol. Vol. 49, pp. 242-243.
34. Schobess, R., Junker, R., Auberger, K. et al. (1999), 'Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis - Evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation', Eur. J. Pediatr. Vol. 158(Suppl. 3), pp. S105-S108.
35. Rees, D.C., Cox, M. and Clegg, J.B. (1995), 'World distribution of factor V Leiden', Lancet Vol. 346, pp. 1133-1134.
36. Miyata, T, Kawasaki, T., Fujimura, H. et al. (1998), 'The prothrombin gene G20210A mutation is not found among Japanese patients with deep vein thrombosis and healthy individuals', Blood Coagul. Fibrinolysis Vol. 9, pp. 451-452.
37. Cumming, A.M., Keeney, S., Salden, A. et al. (1997), 'The prothrombin gene G20210A variant: Prevalence in a UK anticoagulant clinic population', Br. J. Haematol. Vol. 98, pp. 353-355.
38. Cattaneo, M., Chantarangkul, V., Taioli, E. et al. (1999), 'The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: Prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels', Thromb. Res. Vol. 93, pp. 1-8.
39. Margaglione, M., Brancaccio, V., Giuliani, N. et al. (1998), 'Increased risk for venous thrombosis in carriers of the prothrombin G->A20210 gene variant', Ann. Intern. Med. Vol. 129, pp. 89-93.
40. Poort, S.R., Rosendaal, F.R., Reitsma, P.H. and Bertina, R.M. (1996), 'A common genetic variation in the 3 ′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis', Blood Vol. 88, pp. 3698-3703.
41. Sachchithananthan, M., Stasinopoulos, S.J., Wilusz, J. and Medcalf, R.L. (2005), 'The relationship between the prothrombin upstream sequence element and the G20210A polymorphism: The influence of a competitive environment for mRNA 3′-end formation', Nucleic Acids Res. Vol. 33, pp. 1010-1020.
42. Rees, D.C., Chapman, N.H., Webster, M.T. et al. (1999), 'Born to clot: The European burden', Br. J. Haematol. Vol. 105, pp. 564-566.
43. Lesage, S., Zouali, H., Cezard, J.P. et al. (2002), 'CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease', Am. J. Hum. Genet. Vol. 70, pp. 845-857.
44. Hampe, J., Cuthbert, A., Croucher, P.J. et al. (2001), 'Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations', Lancet Vol. 357, pp. 1925-1928.
45. Ogura, Y, Bonen, D.K., Inohara, N. et al. (2001), 'A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease', Nature Vol. 411, pp. 603-606.
46. Hugot, J.P., Chamaillard, M., Zouali, H. et al. (2001), 'Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease', Nature Vol. 411, pp. 599-603.
47. Kim, T.H., Rahman, P, Jun, J.B. et al. (2004), 'Analysis of CARD15 polymorphisms in Korean patients with ankylosing spondylitis reveals absence of common variants seen in western populations', J. Rheumatol. Vol. 31, pp. 1959-1961.
48. Yamazaki, K., Takazoe, M., Tanaka, T. et al. (2002), 'Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease', J. Hum. Genet. Vol. 47, pp. 469-472.
49. Stockton, J.C., Howson, J.M., Awomoyi, A.A. et al. (2004), Polymorphism in NOD2, Crohn's disease, and susceptibility to pulmonary tuberculosis', FEMS Immunol. Med. Microbiol. Vol. 41, pp. 157-160.
50. CHEK2 Breast Cancer Case-Control Consortium (2004), 'CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies', Am. J. Hum. Genet. Vol. 74, pp. 1175-1182.
51. Broeks, A., de Witte, L., Nooijen, A. et al. (2004), 'Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers', Breast Cancer Res. Treat. Vol. 83, pp. 91-93.
52. Cybulski, C., Gorski, B., Huzarski, T. et al. (2004), 'CHEK2 is a multiorgan cancer susceptibility gene', Am. J. Hum. Genet. Vol. 75, pp. 1131-1135.
53. Dufault, M.R., Betz, B., Wappenschmidt, B. et al. (2004), 'Limited relevance of the CHEK2 gene in hereditary breast cancer', Int. J. Cancer Vol. 110, pp. 320-325.
54. Gorski, B., Cybulski, C., Huzarski, T. et al. (2005), 'Breast cancer predisposing alleles in Poland', Breast Cancer Res. Treat. Vol. 92, pp. 19-24.
55. Meijers-Heijboer, H., van den Ouweland, A., Klijn, J. et al. (2002), 'Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations', Nat. Genet. Vol. 31, pp. 55-59.
56. Vahteristo, P, Bartkova, J., Eerola, H. et al. (2002), 'A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer', Am. J. Hum. Genet. Vol. 71, pp. 432-438.
57. Corder, E.H., Saunders, A.M., Risch, N.J. et al. (1993), 'Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families', Science Vol. 261, pp. 921-923.
58. Saunders, A.M., Strittmatter, W.J., Schmechel, D. et al. (1993), 'Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease', Neurology Vol. 43, pp. 1467-1472.
59. Mayeux, R., Stern, Y, Ottman, R. et al. (1993), 'The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease', Ann. Neurol. Vol. 34, pp. 752-754.
60. Anon (1993), 'Apolipoprotein E genotype and Alzheimer's disease. Alzheimer's Disease Collaborative Group', Lancet Vol. 342, pp. 737-738.
61. Strittmatter, W.J. and Roses, A.D. (1995), 'Apolipoprotein E and Alzheimer disease', Proc. Natl. Acad. Sci. USA Vol. 92, pp. 4725-4727.
62. Corbo, R.M. and Scacchi, R. (1999), 'Apolipoprotein E (APOE) allele distribution in the world Is APOE*4 a "thrifty' allele?"', Ann. Hum. Genet. Vol. 63, pp. 301-310.
63. Sayi, J.G., Patel, N.B., Premkumar, D.R. et al. (1997), 'Apolipoprotein E polymorphism in elderly east Africans', East Afr. Med. J. Vol. 74, pp. 668-670.
64. Lane, K.A., Gao, S., Hui, S.L. et al. (2003), 'Apolipoprotein E and mortality in African-Americans and Yoruba', J. Alzheimers Dis. Vol. 5, pp. 383-390.
65. Wu, J.H., Lo, S.K., Wen, M.S. and Kao, J.T. (2002), 'Characterization of apolipoprotein E genetic variations in Taiwanese: Association with coronary heart disease and plasma lipid levels', Hum, Biol. Vol. 74, pp. 25-31.
66. Gloyn, A.L., Weedon, M.N., Owen, K.R. et al. (2003), 'Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes', Diabetes Vol. 52, pp. 568-572.
67. Laukkanen, O., Pihlajamaki, J., Lindstrom, J. et al. (2004), 'Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study', J. Clin. Endocrinol. Metab. Vol. 89, pp. 6286-6290.
68. McCarthy, M.I. (2004), 'Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification', Hum. Mol. Genet. Vol. 13, pp. R33-R41.
69. Dean, M., Carrington, M., Winkler, C. et al. (1996), 'Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study', Science Vol. 273, pp. 1856-1862.
70. Huang, Y, Paxton, W.A., Wolinsky, S.M. et al. (1996), 'The role of a mutant CCR5 allele in HIV-1 transmission and disease progression', Nat. Med. Vol. 2, pp. 1240-1243.
71. Liu, R., Paxton, W.A., Choe, S. et al. (1996), 'Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection', Cell Vol. 86, pp. 367-377.
72. Samson, M., Libert, F., Doranz, B.J. et al. (1996), 'Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene', Nature Vol. 382, pp. 722-725.
73. Zimmerman, P.A., Buckler-White, A., Alkhatib, G. et al. (1997), 'Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk', Mol. Med. Vol. 3, pp. 23-36.
74. Martinson, J.J., Chapman, N.H., Rees, D.C. et al. (1997), 'Global distribution of the CCR5 gene 32-basepair deletion', Nat. Genet. Vol. 16, pp. 100-103.
75. Shiffman, D., Ellis, S.G., Rowland, C.M. et al. (2005), 'Identification of four gene variants associated with myocardial infarction', Am. J. Hum. Genet. Vol. 77, pp. 596-605.
76. Smith, M.W and O'Brien, S.J. (2005), 'Mapping by admixture linkage disequilibrium: Advances, limitations and guidelines', Nat. Rev. Genet. Vol. 6, pp. 623-632.
77. Abecasis, G.R., Ghosh, D. and Nichols, T.E. (2005), 'Linkage disequilibrium: Ancient history drives the new genetics', Hum. Hered. Vol. 59, pp. 118-124.
78. Halder, I. and Shriver, M.D. (2003), 'Measuring and using admixture to study the genetics of complex diseases', Hum. Genomics Vol. 1, pp. 52-62.
79. Vaisse, C., Clement, K., Durand, E. et al. (2000), 'Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity', J. Clin. Invest. Vol. 106, pp. 253-262.
80. Cohen, J.C., Kiss, R.S., Pertsemlidis, A. et al. (2004), 'Multiple rare alleles contribute to low plasma levels of HDL cholesterol', Science Vol. 305, pp. 869-872.
81. Margulies, M., Egholm, M., Altman, E. et al. (2005), 'Genome sequencing in microfabricated high-density picolitre reactors', Nature Vol. 437, pp. 376-380.
82. Faham, M., Zheng, J., Moorhead, M. et al. (2005), 'Multiplexed variation scanning for 1,000 amplicons in hundreds of patients using mismatch repair detection (MRD) on tag arrays', Proc. Natl. Acad. Sci. USA Vol. 102, pp. 14717-14722.
83. Cargill, M., Altshuler, D., Ireland, J. et al. (1999), 'Characterization of single-nucleotide polymorphisms in coding regions of human genes', Nat. Genet. Vol. 22, pp. 231-238.
84. de Bakker, P.I., Yelensky R., Pe'er, I. et al. (2005), 'Efficiency and power in genetic association studies', Nat. Genet. Vol. 37, pp. 1217-1223.
85. Van Eerdewegh, P, Little, R.D., Dupuis, J. et al. (2002), 'Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness', Nature Vol. 418, pp. 426-430.
86. Saleh, M., Vaillancourt, J.P., Graham, R.K. et al. (2004), 'Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms', Nature Vol. 429, pp. 75-79.
87. Kim, T.H., Barrera, L.O., Qu, C. et al. (2005), 'Direct isolation and identification of promoters in the human genome', Genome Res. Vol. 15, pp. 830-839.
88. Ahmadi, K.R., Weale, M.E., Xue, Z.Y. et al. (2005), 'A single-nucleotide polymorphism. tagging set for human drug metabolism and transport', Nat. Genet. Vol. 37, pp. 84-89.
89. Evans, D.M., Cardon, L.R. and Morris, A.P. (2004), 'Genotype prediction using a dense map of SNPs', Genet. Epidemiol, Vol. 27, pp. 375-384.
90. Carlson, C.S., Eberle, M.A., Rieder, M.J. et al. (2004), 'Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium', Am. J. Hum. Genet. Vol. 74, pp. 106-120.
91. Hu, X., Schrodi, S.J., Koss, D.A. and Cargill, M. (2004), 'Selecting tagging SNPs for association studies using power calculations from genotype data', Hum. Hered. Vol. 57, pp. 156-170.
92. Ke, X., Durrant, C., Morris, A.P. et al. (2004), 'Efficiency and consistency of haplotype tagging of dense SNP maps in multiple samples', Hum. Mol. Genet. Vol. 13, pp. 2557-2565.
93. Reich, D.E. and Lander, E.S. (2001), 'On the allelic spectrum of human disease', Trends Genet. Vol. 17, pp. 502-510.
94. Pritchard, J.K. (2001), 'Are rare variants responsible for susceptibility to complex diseases?', Am. J. Hum. Genet. Vol. 69, pp. 124-137.
95. Pritchard, J.K. and Cox, N.J. (2002), 'The allelic architecture of human disease genes: Common disease-common variant...or not?', Hum. Mol. Genet. Vol. 11, pp. 2417-2423.
96. Hirschhorn, J.N. and Daly, M.J. (2005), 'Genome-wide association studies for common diseases and complex traits', Nat. Rev. Genet. Vol. 6, pp. 95-108.
97. Gordon, D., Finch, S.J., Nothnagel, M. and Ott, J. (2002), 'Power and sample size calculations for case-control genetic association tests when errors are present: Application to single nucleotide polymorphisms', Hum. Hered. Vol. 54, pp. 22-33.
98. Fan, J.B., Oliphant, A., Shen, R. et al. (2003), 'Highly parallel SNP genotyping', Cold Spring Harb. Symp. Quant. Biol. Vol. 68, pp. 69-78.
99. Hardenbol, P., Yu, E, Belmont, J. et al. (2005), 'Highly multiplexed molecular inversion probe genotyping: Over 10,000 targeted SNPs genotyped in a single tube assay', Genome Res. Vol. 15, pp. 269-275.
100. Reich, D.E. and Goldstein, D.B. (2001), 'Detecting association in a case-control study while correcting for population stratification', Genet. Epidemiol. Vol. 20, pp. 4-16.
101. Falush, D., Stephens, M. and Pritchard, J.K. (2003), 'Inference of population structure using multilocus genotype data: Linked loci and correlated allele frequencies', Genetics Vol. 164, pp. 1567-1587.
102. Jones, H.B. and Faham, M. (2005), 'Evidence and implications for multiplicative interactions among loci predisposing to human common disease', Hum. Hered. Vol. 59, pp. 176-184.
103. Sunyaev, S., Ramensky, V, Koch, I. et al. (2001), 'Prediction of deleterious human allele', Hum. Mol, Genet. Vol. 10, pp. 591-597.
104. Ramensky, V, Bork, P. and Sunyaev, S. (2002), 'Human non-synonymous SNPs: Server and survey', Nucleic Acids Res. Vol. 30, pp. 3894-3900.
105. Ireland, J., Carlton, V.E., Falkowski, M. et al. (2006), 'Large-scale characterization of public database SNPs causing non-synonymous changes in three ethnic groups', Hum. Genet. Vol. 119, pp. 75-83.
106. Lin, S., Chakravarti, A. and Cutler, D.J. (2004), 'Exhaustive allelic transmission disequilibrium tests as a new approach to genome-wide association studies', Nat. Genet. Vol. 36, pp. 1181-1188.
107. Altshuler, D., Hirschhorn, J.N., Klannemark, M. et al. (2000), 'The common PPARgamma Prol2Ala polymorphism. is associated with decreased risk of type 2 diabetes', Nat. Genet. Vol. 26, pp. 76-80.
108. Haga, H., Yamada, R., Ohnishi, Y. et al. (2002), 'Gene-based SNP discovery as part of the Japanese Millennium Genome Project 2002. Identification of 190,562 genetic variations in the human genome', J. Hum. Genet. Vol. 47, pp. 605-610.
109. Botstein, D. and Risch, N. (2003), 'Discovering genotypes underlying human phenotypes: Past successes for Mendelian disease, future approaches for complex disease', Nat. Genet. Vol. 33, pp. 228-237.
110. Halushka, M.K., Fan, J.-B., Bentley, K. et al. (1999), 'Patterns of single-nucleotide polymorphisms, in candidate genes for blood-pressure homeostasis', Nat. Genet. Vol. 22, pp. 239-247.
111. Cargill, M., Altshuler, D., Ireland, J. et al. (1999), 'Characterization of single-nucleotide polymorphisms in coding regions of human genes', Nat. Genet. Vol. 22, pp. 231-238.
112. Siepel, A., Bejerano, G., Pedersen, J.S. et al. (2005), 'Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes', Genome Res. Vol. 15, pp. 1034-1050.
113. Crawford, D.C., Akey, D.T. and Nickerson, D.A. (2005), 'The patterns of natural variation in human genes', Annu. Rev. Genomics Hum. Genet. Vol. 6, pp. 287-312.
114. Krawczak, M., Reiss, J. and Cooper, D.N. (1992), 'The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences', Hum. Genet. Vol. 90, pp. 41-54.
115. Treisman, R., Orkin, S.H. and Maniatis, T. (1983), 'Specific transcription and RNA splicing defects in five cloned beta-thalassaemia genes', Nature Vol. 302, pp. 591-596.
116. Mitchell, G.A., Labuda, D., Fontaine, G. et al. (1991), 'Splice-mediated insertion of an Alu sequence inactivates ornithine delta-aminotransferase: A role for Alu elements in human mutation', Proc. Natl. Acad. Sci. USA Vol. 88, pp. 815-819.
117. Pagani, F., Buratti, E., Stuani, C. et al. (2002), 'A new type of mutation causes a splicing defect in ATM', Nat. Genet. Vol. 30, pp. 426-429.
118. Min, G.L., Martiat, P., Pu, G.A. and Goldman, J. (1990), 'Use of pulsed field gel electrophoresis to characterize BCR gene involvement in CML patients lacking M-BCR rearrangement', Leukemia Vol. 4, pp. 650-656.
119. Zhang, X.H., Leslie, C.S. and Chasin, L.A. (2005), 'Dichotomous splicing signals in exon flanks', Genome Res. Vol. 15, pp. 768-779.
120. Fairbrother, W.G., Holste, D., Burge, C.B. and Sharp, P.A. (2004), 'Single nucleotide polymorphism-based validation of exonic splicing enhancers', PLoS Biol. Vol. 2, p. E268.
121. Senapathy, P, Shapiro, M.B. and Harris, N.L. (1990), 'Splice junctions, branch point sites, and exons: Sequence statistics, identification, and applications to genome project', Methods Enzymol. Vol. 183, pp. 252-278.
122. Cartegni, L., Chew, S.L. and Krainer, A.R. (2002), 'Listening to silence and understanding nonsense: Exonic mutations that affect splicing', Nat. Rev. Genet. Vol. 3, pp. 285-298.
123. Liu, H.X., Zhang, M. and Krainer, A.R. (1998), 'Identification of functional exonic splicing enhancer motifs recognized by individual SR, proteins', Genes Dev. Vol. 12, pp. 1998-2012.
124. Schaal, T.D. and Maniatis, T. (1999), 'Multiple distinct splicing enhancers in the protein-coding sequences of a constitutively spliced pre-mRNA', Mol. Cell Biol. Vol. 19, pp. 261-273.
125. Zhang, X.H. and Chasin, L.A. (2004), 'Computational definition of sequence motifs governing constitutive exon splicing', Genes Dev. Vol, 18, pp. 1241-1250.
126. Fairbrother, W.G., Yeh, R.F., Sharp, P.A. and Burge, C.B. (2002), 'Predictive identification of exonic splicing enhancers in human genes', Science Vol. 297, pp. 1007-1113.
127. Smale, S.T. and Kadonaga, J.T. (2003), 'The RNA polymerase II core promoter', Annu. Rev. Biochem. Vol. 72, pp. 449-479.
128. Callahan III, R. and Balbinder, E. (1970), 'Tryptophan operon: Structural gene mutation creating a 'promoter' and leading to 5-methyltryptophan dependence', Science Vol. 168, pp. 1586-1589.
129. Roberts, J.W (1969), 'Promoter mutation in vitro', Nature Vol. 223, pp. 480-482.
130. Kulozik, A.E., Bellan-Koch, A., Bail, S. et al. (1991), 'Thalassemia intermedia: Moderate reduction of beta globin gene transcriptional activity by a novel mutation of the proximal CACCC promoter element', Blood Vol. 77, pp. 2054-2058.
131. Bosma, P.J., Chowdhury, J.R,., Bakkerm, C. et al. (1995), 'The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome', N. Engl. J. Med. Vol. 333, pp. 1171-1175.
132. Trinklein, N.D., Aldred, S.J., Saldanha, A.J. and Myers, R.M. (2003), 'Identification and functional analysis of human transcriptional promoters', Genome Res. Vol. 13, pp. 308-312.
133. Imanishi, T., Itoh, T., Suzuki, Y. et al. (2004), 'Integrative annotation of 21,037 human genes validated by full-length cDNA clones', PLoS Biol. Vol. 2, p. e162.
134. Suzuki, Y., Yamashita, R., Sugano, S. and Nakai, K. (2004), 'DBTSS, DataBase of Transcriptional Start Sites: Progress report 2004', Nucleic Acids Res. Vol. 32, pp. D78-D81.
135. Suzuki, Y, Yamashita, R., Shirota, M. et al. (2004), 'Large-scale collection and characterization of promoters of human and mouse genes', In Silico Biol. Vol. 4, pp. 429-444.
136. Rodriguez-Jato, S., Nicholls, R.D., Driscoll, D.J. and Yang, T.P. (2005), 'Characterization of cis- and trans-acting elements in the imprinted human SNURF-SNRPN locus', Nucleic Acids Res. Vol. 33, pp. 4740-4753.
137. Lettice, L.A., Heaney, S.J., Purdie, L.A. et al. (2003), 'A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyl', Hum. Mol. Genet. Vol. 12, pp. 1725-1735.
138. The ENCODE (ENCyclopedia Of DNA Elements) Project (2004), Science Vol. 306, pp. 636-640.
139. Kolbe, D., Taylor, J., Elnitski, L. et al. (2004), 'Regulatory potential scores from genome-wide three-way alignments of human, mouse, and rat', Genome Res. Vol. 14, pp. 700-707.
140. Elnitski, L., Hardison, R.C., Li, J. et al. (2003), 'Distinguishing regulatory DNA from neutral sites', Genome Res. Vol. 13, pp. 64-72.
141. Woolfe, A., Goodson, M., Goode, D.K. et al. (2005), 'Highly conserved non-coding sequences are associated with vertebrate development', PloS Biol. Vol. 3, p. e7.
142. Dermitzakis, E.T, Reymond, A., Lyle, R. et al. (2002), 'Numerous potentially functional but non-genic conserved sequences on human chromosome 21', Nature Vol. 420, pp. 578-582.
143. Cooper, G.M., Stone, E.A., Asimenos, G. et al. (2005), 'Distribution and intensity of constraint in mammalian genomic sequence', Genome Res. Vol. 15, pp. 901-913.
144. Dermitzakis, E.T., Reymond, A. and Antonarakis, S.E. (2005), 'Conserved non-genic sequences - An unexpected feature of mammalian genomes', Nat. Rev. Genet. Vol. 6, pp. 151-157.
145. Margulies, E.H., Blanchette, M., Haussler, D. and Green, E.D. (2003), 'Identification and characterization of multi-species conserved sequences', Genome Res. Vol. 13, pp. 2507-2518.
146. Boffelli, D., McAuliffe, J., Ovcharenko, D. et al. (2003), 'Phylogenetic shadowing of primate sequences to find functional regions of the human genome', Science Vol. 299, pp. 1391-1394.
147. Frazer, K.A., Tao, H., Osoegawa, K. et al. (2004), 'Noncoding sequences conserved in a limited number of mammals in the SIM2 interval are frequently functional', Genome Res. Vol. 14, pp. 367-372.
148. Pennacchio, L.A. and Rubin, E.M. (2001), 'Genomic strategies to identify mammalian regulatory sequences', Nat. Rev. Genet. Vol. 2, pp. 100-109.
149. Hardison, R.C. (2003),'Comparative genomics', PLoS Biol. Vol. 1, p. E58.
150. Culi, J. and Modolell, J. (1998), 'Proneural gene self-stimulation in neural precursors: An essential mechanism for sense organ development that is regulated by Notch signaling', Genes Dev. Vol. 12, pp. 2036-2047.
151. Renucci, A., Zappavigna, V, Zàkgrany, J. et al. (1992), 'Comparison of mouse and human HOX-4 complexes defines conserved sequences involved in the regulation of Hox-4.4', EMBO J. Vol. 11, pp. 1459-1468.
152. Loots, G.G., Locksley, R.M., Blankespoor, C.M. et al. (2000), 'Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons', Science Vol. 288, pp. 136-140.
153. Poulin, F., Nobrega, M.A., Plajzer-Frick, I. et al. (2005), 'In vivo characterization of a vertebrate ultraconserved enhancer', Genomics Vol. 85, pp. 774-781.
154. Nobrega, M.A., Ovcharenko, I., Afzal, V and Rubin, E.M. (2003), 'Scanning human gene deserts for long-range enhancers', Science Vol. 302, pp. 413.
155. Kimura-Yoshida, C., Kitajima, K., Oda-Ishii, I. et al. (2004), 'Characterization of the pufferfish Otx2 cis-regulators reveals evolutionarily conserved genetic mechanisms for vertebrate head specification', Development Vol. 131, pp. 57-71.
156. Uchikawa, M., Takemoto, T., Kamachi, Y and Kondoh, H. (2004), 'Efficient identification ofregulatory sequences in the chicken genome by a powerful combination of embryo electroporation and genome comparison', Mech. Dev. Vol. 121, pp. 1145-1158.
157. Ganley, A.R., Hayashi, K., Horiuchi, T. and Kobayashi, T. (2005), 'Identifying gene-independent noncoding; functional elements in the yeast ribosomal DNA by phylogenetic footprinting', Proc. Natl. Acad. Sci. USA Vol. 102, pp. 11787-11792.
158. Xie, X., Lu, J., Kulbokas, E.J. et al. (2005), 'Systematic discovery of regulatory motifs in human promoters and 3′ UTRS by comparison of several mammals', Nature Vol. 434, pp. 338-345.
159. Glazko, G.V, Koonin, E.V, Rogozin, I.B. and Shabalina, S.A. (2003), 'A significant fraction of conserved noncoding DNA in human and mouse consists of predicted matrix attachment regions', Trends Genet. Vol. 19, pp. 119-124.
160. Drake, J.A., Bird, C., Nemesh, J. et al, (2006), 'Conserved noncoding sequences are selectively constrained and not mutation cold spots', Nat. Genet. Vol. 38, pp. 223-227.
161. Altshuler, D., Brooks, L.D., Chakravarti, A. et al. (2005), 'A haplotype map of the human genome', Nature Vol. 437, pp. 1299-1320.
162. Boffelli, D., Nobrega, M.A. and Rubin, E.M. (2004), 'Comparative genomics at the vertebrate extremes', Nat. Rev. Genet. Vol. 5, pp. 456-465.
163. Clark, A.G., Glanowski, S., Nielsen, R. et al. (2003), 'Inferring nonneutral evolution from human-chimp-mouse orthologous gene trios', Science Vol. 302, pp. 1960-1963.
164. Gilad, Y., Bustamante, C.D., Lancet, D. and Paabo, S. (2003), 'Natural selection on the olfactory receptor gene family in humans and chimpanzees', Am. J. Hum. Genet. Vol. 73, pp. 489-501.
165. Kellis, M., Patterson, N., Endrizzi, M. et al. (2003), 'Sequencing and comparison of yeast species to identify genes and regulatory elements', Nature Vol. 423, pp. 241-254.
166. Gibbs, R.A., Weinstock, G.M., Metzker, M.L. et al. (2004), 'Genome sequence of the Brown Norway rat yields insights into mammalian evolution', Nature Vol. 428, pp. 493-521.
167. Kruglyak, L. and Nickerson, D.A. (2001), 'Variation is the spice of life', Nat. Genet. Vol. 27, pp. 234-236.
168. The International Consortium (2005), 'A haplotype map of the human genome', Nature Vol. 437, pp. 1299-1320.
169. Matsuzaki, H., Dong, S., Loi, H. et al. (2004), 'Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays', Nat. Methods Vol. 1, pp. 109-111.
170. Fakhrai-Rad, H., Zheng, J., Willis, T.D. et al. (2004), 'SNP discovery in pooled samples with mismatch repair detection', Genome Res. Vol. 14, pp. 1404-1412.